Clinical Trials

• NCT07573215

  RMC-6236-401-RevMed's expanded access program; daraxonrasib (EAP) managed by Bionical Emas

  This study is currently enrolling.

  Associated Conditions: Gastrointestinal

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT02700464

  Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma: A Retrospective Longitudinal Chart Review (RCR) for Subjects Previously Enrolled under Study Protocol UC-EpiCheck-FDA-01

  This study is currently enrolling.

  Associated Conditions: Urology of Denver

  Research Area: Colorado Cancer Research

  Research Location: Porter, Colorado
• NCT07452458

  Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

  This study is currently enrolling.

  Associated Conditions: Radiation

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT06743126

  A prospective, multicenter, open-label, randomized, actively controlled, parallel-group Phase 3 clinical trial to evaluate efficacy, safety, and tolerability of IMA203 versus investigator’s choice of treatment in patients with previously treated, unresectable or metastatic cutaneous melanoma (ACTengine® IMA203-301)

  This study is currently enrolling.

  Associated Conditions: Skin

  Research Area: Clinical Cancer Research

  Research Location: Orlando

• Surgical drain fluid for detection of molecular residual disease (MRD) in patients with HPV(-) head and neck cancers

  This study is currently enrolling.

  Associated Conditions: Head & Neck

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT06422806

  A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas

  This study is currently enrolling.

  Associated Conditions: Sarcoma

  Research Area: Clinical Cancer Research

  Research Location: Orlando

• A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)

  This study is currently enrolling.

  Associated Conditions: Radiation

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT06810141

  ResQ132EX-NMIBC: Expanded Access Use of Recombinant Bacillus Calmette-Guérin in Nonmuscle Invasive Bladder Cancer

  This study is currently enrolling.

  Associated Conditions: Urology of Denver

  Research Area: Colorado Cancer Research
• NCT07166406

  NRG-GI012: PHASE III RANDOMIZED TRIAL OF IO-BASED SYSTEMIC TREATMENT +/- LIVER SBRT IN HEPATOCELLULAR CANCER WITH MACROVASCULAR INVASION (HELIO-RT)

  This study is currently enrolling.

  Associated Conditions: Radiation

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT07359352

  Surgical Care And Recovery with Laser Evaluation Trial (S.C.A.R.L.E.T.)

  This study is currently enrolling.

  Associated Conditions: GI / Hepatology

  Research Area: Digestive Health and Surgery

  Research Location: Orlando
• NCT07225946

  A Phase 3 Randomized, Open-label Study of JNJ-78278343, a T Cell-redirecting agent targeting Human Kallikrein 2, with Docetaxel Versus Docetaxel for Metastatic Castration-Resistant Prostate Cancer (KLK2-PASenger)

  This study is currently enrolling.

  Associated Conditions: Genitourinary

  Research Area: Clinical Cancer Research

  Research Location: Orlando
• NCT06393374

  A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab (MK-3475) Versus Treatment of Physician’s Choice (TPC) in Participants with Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery

  This study is currently enrolling.

  Associated Conditions: Breast

  Research Area: Clinical Cancer Research

  Research Location: Orlando